Stockreport

Vir Biotechnology (NASDAQ:VIR) shareholders have endured a 76% loss from investing in the stock three years ago [Yahoo! Finance]

Vir Biotechnology, Inc.  (VIR) 
PDF NASDAQ:VIR ); the share price is down a whopping 76% in the last three years. That would be a disturbing experience. Shareholders have had an even rougher run lately, wi [Read more]